|
|
Claus Christiansen, M.D, is the President and Co-Founder of CCBR. Claus Christiansen is also CCBR founder and the Executive Director of Nordic Bioscience, Denmark. Over the past 30 years, he has published extensively in the field of calcium metabolism, particularly regarding osteoporosis in postmenopausal women, as well as in the field of cardiovascular disease. CCBR and Dr Christiansen are world-famous for high-quality clinical trials and for their important contributions to basic and clinical research. Professor Christiansen has published extensively in the field of osteoporosis with over 800 articles and book chapters, particularly in the area of calcium metabolism in postmenopausal women. He has been Chairman of several international symposia on osteoporosis, and has been an invited speaker on calcium metabolism at almost all international meetings in the field. He is also a member of the Editorial Boards of the journals Bone and Osteoporosis International. |
Working with CCBR speeds up and drives efficiencies in clinical trials by offering greater numbers of patients across fewer sites
A Global Footprint covering more than 20 dedicated Clinical Research Centers in high density population areas
Uniform SOPs enable the tightest possible adherence to study protocols and consistency across all CCBR sites
Real-Time tacking of subject enrolment and trial progress ensures sponsors have the most up to date information, all of the time
Centralised, standardised billing affords better visibility into trial costs for sponsors
